健喬 (4114.TWO)

38.55 -0.30 (-0.77%) 收市：01:30PM CST

健喬

No. 396, Neihu Road
11th Floor Section 1 Neihu District
Taipei 114
Taiwan
886 2 8797 7100
https://www.synmosa.com.tw

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Chih-Hui Lin	Chairman, GM, Managerial Officer & President	4.71M	無	1983
Mr. Hong-Qin Bai	Senior VP & Finance Officer	3.5M	無	無
Ms. Jia-Xin Zhang	Senior Vice President	3.02M	無	無
Mr. Sheng-Ren Yang	Senior Vice President	3.14M	無	無
Mr. Hung-Chin Pai	Senior VP & Accounting Officer	無	無	無
Mr. Zen Young	Vice President of Sales - HP, Marketing & Medical	無	無	無

截止 2020年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 TWD。

描述

Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms. It also offers contract manufacturing services. In addition, it exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. Synmosa Biopharma Corporation was incorporated in 1980 and is based in Taipei, Taiwan.

公司管治

截至 無 止，健喬 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。